Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Koji Haratani, M.D., Ph.D.

Concepts (190)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Koji Haratani's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Koji Haratani has written about over time.
Acrylamides, 1 publications between 2015 and 2015, average publication date October 2015. Biomarkers, Pharmacological, 1 publications between 2018 and 2018, average publication date February 2018. Immune System Diseases, 1 publications between 2018 and 2018, average publication date February 2018. Antibodies, Monoclonal, 5 publications between 2017 and 2024, average publication date October 2018. Receptor, ErbB-3, 6 publications between 2016 and 2021, average publication date December 2018. Lymphocytes, Tumor-Infiltrating, 3 publications between 2017 and 2020, average publication date January 2019. Immunoconjugates, 2 publications between 2019 and 2020, average publication date September 2019. Neoplasms, Unknown Primary, 1 publications between 2019 and 2019, average publication date September 2019. Protein Kinase Inhibitors, 11 publications between 2017 and 2022, average publication date October 2019. Neoplasms, Experimental, 1 publications between 2020 and 2020, average publication date January 2020. Drug Resistance, Neoplasm, 10 publications between 2016 and 2023, average publication date January 2020. Lung Neoplasms, 30 publications between 2015 and 2024, average publication date September 2020. Carcinoma, Non-Small-Cell Lung, 28 publications between 2017 and 2024, average publication date September 2020.

To see the data from this visualization as text, click here.
Haratani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (190)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.